메뉴 건너뛰기




Volumn 66, Issue 24, 2010, Pages 4370-4376

Mechanism and synthesis of pharmacologically active quinolones from Morita-Baylis-Hillman adducts

Author keywords

4 Quinolones; Alzheimer disease; Antibiotics; Morita Baylis Hillman; N Oxides

Indexed keywords

1 ( 4 METHOXYBENZYL) 4 OXO 1,4 DIHYDROISOQUINOLINE 3 CARBOXYLIC ACID; 1 ETHYL 6 FLUORO 4 OXO 7 (PIPERAZIN 1 YL) 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID; BENZYL QUINOLONE CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; MUSCARINIC M1 RECEPTOR; NORFLOXACIN; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 77953123744     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.04.018     Document Type: Article
Times cited : (43)

References (106)
  • 16
    • 77957198645 scopus 로고    scopus 로고
    • Chem. Abstr. 147 (2007) 9883
    • (2007) Chem. Abstr. , vol.147 , pp. 9883
  • 20
  • 21
    • 77953119784 scopus 로고    scopus 로고
    • Chem. Abstr. 147 (2007) 343962
    • (2007) Chem. Abstr. , vol.147 , pp. 343962
  • 23
    • 77953123065 scopus 로고    scopus 로고
    • Chem. Abstr. 147 (2007) 72652
    • (2007) Chem. Abstr. , vol.147 , pp. 72652
  • 24
    • 70450270803 scopus 로고    scopus 로고
    • For a comprehensive review concerning the chemistry of quinolones, see:
    • For a comprehensive review concerning the chemistry of quinolones, see:. Boteva A.A., and Krasnykh O.P. Chem. Heterocycl. Compd. 45 (2009) 757-785
    • (2009) Chem. Heterocycl. Compd. , vol.45 , pp. 757-785
    • Boteva, A.A.1    Krasnykh, O.P.2
  • 25
    • 77953121314 scopus 로고    scopus 로고
    • For some examples concerning the synthesis of Norfloxacin, see
    • For some examples concerning the synthesis of Norfloxacin, see:
  • 33
    • 77953119699 scopus 로고    scopus 로고
    • For some recent review concerning different aspects of the Morita-Baylis-Hillman reaction, see
    • For some recent review concerning different aspects of the Morita-Baylis-Hillman reaction, see:
  • 37
    • 77953123237 scopus 로고    scopus 로고
    • For new insights about the mechanism of this reaction, see
    • For new insights about the mechanism of this reaction, see:
  • 47
    • 77953120821 scopus 로고    scopus 로고
    • For examples for the use of MBH adducts as substrate for natural products synthesis, see
    • For examples for the use of MBH adducts as substrate for natural products synthesis, see:
  • 61
    • 77953121072 scopus 로고    scopus 로고
    • For recent examples of the use of MBH adducts as starting materials for heterocycles synthesis, see
    • For recent examples of the use of MBH adducts as starting materials for heterocycles synthesis, see:
  • 75
    • 77953119838 scopus 로고    scopus 로고
    • Chem. Abstr. 144 (2005) 350460
    • (2005) Chem. Abstr. , vol.144 , pp. 350460
  • 86
    • 77953120664 scopus 로고    scopus 로고
    • For examples of ESI-MS monitoring of key organic reactions see
    • For examples of ESI-MS monitoring of key organic reactions see:
  • 95
    • 84891563356 scopus 로고    scopus 로고
    • Santos L.S. (Ed), Wiley-VCH, Weinheim
    • In: Santos L.S. (Ed). Reactive Intermediates (2010), Wiley-VCH, Weinheim
    • (2010) Reactive Intermediates
  • 106
    • 77956906495 scopus 로고
    • Norfloxacin
    • Florey K. (Ed), Academic, San Diego
    • Mazuel C. Norfloxacin. In: Florey K. (Ed). Analytical Profiles of Drug Substances (1991), Academic, San Diego 557-600
    • (1991) Analytical Profiles of Drug Substances , pp. 557-600
    • Mazuel, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.